{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:15:43Z","timestamp":1790615743597,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the efficacy and safety of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women. Topical 5% cysteamine is an antioxidant and tyrosinase inhibitor that has been shown to be effective in the treatment of melasma. However, to date, no study has compared the performance of topical cysteamine to hydroquinone for facial melasma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A quasi\u2010randomized, multicenter, evaluator\u2010blinded clinical trial was conducted on 40 women with facial melasma who were submitted to the nightly application of 5% cysteamine (CYS) or 4% hydroquinone (HQ) on hyperpigmented areas for 120\u00a0days. Both groups were required to use tinted sunscreen (SPF 50; PPD 19). Subjects were assessed at the inclusion and after 60 and 120\u00a0days of treatment for mMASI, MELASQoL, and the difference in colorimetric luminosity between melasma and the adjacent unaffected skin. The Global Aesthetic Improvement Scale was used to assess the difference in the appearance of the skin through standardized photographs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean reduction of the mMASI scores was 24% for CYS and 41% for HQ (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.015) at 60\u00a0days, and 38% for CYS and 53% for HQ (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.017) at 120\u00a0days. The photographic evaluation revealed up to 74% improvement for both groups, without statistically significant difference between them (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.087). The MELASQoL score showed a progressive decrease for both groups over time, despite the greater reduction for HQ after 120\u00a0days (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.018). Colorimetric assessment disclosed progressive depigmenting in both groups, without statistically significant difference between them (<jats:italic>P<\/jats:italic>\u00a0&gt;\u00a00.160). No severe adverse effects were identified in either group. Erythema and burning were the most important local adverse effects with cysteamine, although their frequency did not differ between groups (<jats:italic>P<\/jats:italic>\u00a0&gt;\u00a00.170).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Cysteamine proved to be safe, well\u2010tolerated, and effective, despite its inferior performance to hydroquinone in decreasing mMASI and MELASQoL in the treatment of melasma.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijd.15146","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T08:40:48Z","timestamp":1598863248000},"page":"1531-1536","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women"],"prefix":"10.1111","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4659-2155","authenticated-orcid":false,"given":"Paula Basso","family":"Lima","sequence":"first","affiliation":[{"name":"Departamento de Dermatologia e Radioterapia FMB\u2010Unesp Botucatu Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9435-2303","authenticated-orcid":false,"given":"Joana Alexandria Ferreira","family":"Dias","sequence":"additional","affiliation":[{"name":"Departamento de Dermatologia e Radioterapia FMB\u2010Unesp Botucatu Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2615-0456","authenticated-orcid":false,"given":"Daniel","family":"Cassiano","sequence":"additional","affiliation":[{"name":"Departamento de Dermatologia UNIFESP S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-2354","authenticated-orcid":false,"given":"Ana Cl\u00e1udia Cavalcante","family":"Esposito","sequence":"additional","affiliation":[{"name":"Departamento de Dermatologia e Radioterapia FMB\u2010Unesp Botucatu Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-8241","authenticated-orcid":false,"given":"Edil\u00e9ia","family":"Bagatin","sequence":"additional","affiliation":[{"name":"Departamento de Dermatologia UNIFESP S\u00e3o Paulo Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2388-7842","authenticated-orcid":false,"given":"Luciane Donida Bartoli","family":"Miot","sequence":"additional","affiliation":[{"name":"Departamento de Dermatologia e Radioterapia FMB\u2010Unesp Botucatu Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-9294","authenticated-orcid":false,"given":"H\u00e9lio Amante","family":"Miot","sequence":"additional","affiliation":[{"name":"Departamento de Dermatologia e Radioterapia FMB\u2010Unesp Botucatu Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13059"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00488-w"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13182"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.001"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/ics.12464"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20152771"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903341945"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01670.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.1968.13"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2013.02.003"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13424"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1351608"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12837"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20143063"},{"key":"e_1_2_6_16_1","first-page":"S0190\u20109622(20)3","article-title":"Efficacy and safety of microneedling and oral tranexamic acid in the treatment of facial melasma in women: an open, evaluator\u2010blinded, randomized clinical trial","volume":"82","author":"Cassiano D","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000546"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.10.051"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07591.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20165014"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1590\/1677-5449.174118"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04430.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.1006"},{"key":"e_1_2_6_24_1","first-page":"10.1111\/srt.129","article-title":"Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in comparison with modified Kligman's formula in subjects with epidermal melasma: a randomized, double\u2010blind clinical trial study","author":"Karrabi M","year":"2020","journal-title":"Skin Res Technol"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2020.32.2.101"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-019-01979-w"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/ics.12186"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ics.12468"},{"key":"e_1_2_6_29_1","first-page":"28","article-title":"Novel combination of a 650\u2010microsecond neodymium\u2010doped yttrium aluminium garnet 1,064\u2010nm laser and cysteamine cream for the treatment of melasma: a case study","volume":"13","author":"Johnson B","year":"2020","journal-title":"J Clin Aesthet Dermatol"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.15146","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijd.15146","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.15146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T18:35:42Z","timestamp":1693766142000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijd.15146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1111\/ijd.15146"],"URL":"https:\/\/doi.org\/10.1111\/ijd.15146","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"2020-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}